Total Payments
$73,511
2024 Payments
$22,858
Companies
19
Transactions
364
Medicare Patients
2,896
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$52,810 (71.8%)
Food & Beverage$13,506 (18.4%)
Consulting$4,040 (5.5%)
Travel$2,932 (4.0%)
Education$222.98 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $52,810 | 32 | 71.8% |
| Food and Beverage | $13,506 | 301 | 18.4% |
| Consulting Fee | $4,040 | 1 | 5.5% |
| Travel and Lodging | $2,932 | 20 | 4.0% |
| Education | $222.98 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $24,089 | 41 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $23,991 | 79 | $0 (2024) |
| Allergan, Inc. | $9,155 | 29 | $0 (2021) |
| ABBVIE INC. | $6,108 | 12 | $0 (2024) |
| Alkermes, Inc. | $2,701 | 62 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $2,085 | 55 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $1,475 | 22 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $902.57 | 21 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $631.53 | 6 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $540.33 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,858 | 96 | Teva Pharmaceuticals USA, Inc. ($20,645) |
| 2023 | $1,848 | 42 | Alkermes, Inc. ($705.39) |
| 2022 | $6,662 | 44 | ABBVIE INC. ($5,960) |
| 2021 | $4,773 | 27 | Teva Pharmaceuticals USA, Inc. ($2,842) |
| 2020 | $1,867 | 19 | Allergan, Inc. ($1,576) |
| 2019 | $13,870 | 52 | Allergan Inc. ($5,952) |
| 2018 | $19,932 | 56 | Neurocrine Biosciences, Inc. ($18,280) |
| 2017 | $1,702 | 28 | Otsuka America Pharmaceutical, Inc. ($619.62) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: CNS | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $101.49 | General |
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Central Nervous System | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $4.09 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: CNS | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $132.04 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: CNS | ||||||
| 11/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: CNS | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: CNS | ||||||
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $120.12 | General |
| Category: CNS | ||||||
| 10/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: CNS | ||||||
| 10/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: CNS | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $121.56 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $142.85 | General |
| Category: Neuroscience | ||||||
| 09/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $110.72 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $140.52 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Neurology | ||||||
| 08/14/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $68.82 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 774 | 4,227 | $536,290 | $292,461 |
| 2022 | 6 | 749 | 4,591 | $580,695 | $296,770 |
| 2021 | 7 | 587 | 3,457 | $438,590 | $228,590 |
| 2020 | 10 | 786 | 3,589 | $454,243 | $229,928 |
Total Patients
2,896
Total Services
15,864
Medicare Billing
$1.0M
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 202 | 3,206 | $384,720 | $207,476 | 53.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 128 | 182 | $50,050 | $25,110 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 414 | $41,400 | $24,068 | 58.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 191 | 230 | $34,500 | $20,387 | 59.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 78 | 102 | $16,320 | $9,697 | 59.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 72 | 93 | $9,300 | $5,724 | 61.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 200 | 3,476 | $417,120 | $204,975 | 49.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 242 | 378 | $56,700 | $28,923 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 458 | $45,800 | $27,491 | 60.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 110 | 157 | $43,175 | $25,455 | 59.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 72 | 95 | $15,200 | $8,372 | 55.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 26 | 27 | $2,700 | $1,553 | 57.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 203 | 2,782 | $333,840 | $165,833 | 49.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 112 | 136 | $37,400 | $21,740 | 58.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 267 | $26,700 | $19,203 | 71.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 93 | 161 | $24,150 | $12,426 | 51.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 69 | 82 | $13,120 | $7,358 | 56.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 12 | $1,680 | $1,037 | 61.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 13 | 17 | $1,700 | $992.63 | 58.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 267 | 2,264 | $274,368 | $137,206 | 50.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 101 | 704 | $70,400 | $36,180 | 51.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 119 | 135 | $37,845 | $22,651 | 59.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 165 | 217 | $32,550 | $16,743 | 51.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 71 | 77 | $12,320 | $6,944 | 56.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 44 | $11,160 | $3,864 | 34.6% |
About Dr. Samuel Etchie, M.D
Dr. Samuel Etchie, M.D is a Psychiatry healthcare provider based in La Mesa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124039052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Etchie, M.D has received a total of $73,511 in payments from pharmaceutical and medical device companies, with $22,858 received in 2024. These payments were reported across 364 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,810).
As a Medicare-enrolled provider, Etchie has provided services to 2,896 Medicare beneficiaries, totaling 15,864 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location La Mesa, CA
- Active Since 08/09/2006
- Last Updated 08/23/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1124039052
Products in Payments
- INGREZZA (Drug) $24,089
- VRAYLAR (Drug) $15,191
- UZEDY (Drug) $15,032
- AUSTEDO (Drug) $3,170
- LATUDA (Drug) $1,953
- ARISTADA (Drug) $1,527
- REXULTI (Drug) $1,362
- NUPLAZID (Drug) $902.57
- LYBALVI (Drug) $643.35
- ABILIFY MAINTENA (Drug) $629.28
- CAPLYTA (Drug) $456.06
- Aristada 441 mg (Drug) $431.53
- INVEGA SUSTENNA (Drug) $410.47
- NEUROSTAR TMS THERAPY (Device) $383.95
- Auvelity (Drug) $355.97
- FANAPT (Drug) $247.33
- COBENFY (Drug) $136.13
- NUEDEXTA (Drug) $125.96
- SPRAVATO (Drug) $124.86
- Vivitrol 380 mg (Drug) $99.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in La Mesa
Brian Miller, M.d, M.D
Psychiatry — Payments: $132,703
Psychiatry $132,703
Mrs. Nita Paintal, Md, MD
Psychiatry — Payments: $5,451
Psychiatry $5,451
Dr. Jonathan Koelle, Md, MD
Psychiatry — Payments: $2,587
Psychiatry $2,587
Dr. Jon Highum, M.d, M.D
Psychiatry — Payments: $1,911
Psychiatry $1,911
Sanjay Rao, M.d, M.D
Psychiatry — Payments: $1,638
Psychiatry $1,638
Dr. Vladimir Khalafian, M.d, M.D
Psychiatry — Payments: $612.66
Psychiatry $612.66